PATENT CLAIM ANALYSIS

Application Number: 16123175
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-05
Patent Classification: ["424", "495000"]

Abstract:
A composition for use in the treatment of a condition or disorder related to mucosal barrier dysfunction in the gut, the composition comprising activated carbon. The condition may be, for example, pouchitis or proctitis.

Claim (Index 12):
A composition according to  claim 1 ,  8 ,  9 ,  10  or  11  wherein the insoluble semipermeable material comprises one or more of ethyl cellulose, glycerylmonostearate, cellulose acetate butyrate, dipolylactic acid, polyvinyl chloride, and a poly(meth)acrylate polymer such as EUDRAGIT\u00ae RL 100, EUDRAGIT\u00ae RL PO, EUDRAGIT\u00ae RL 30D, EUDRAGIT\u00ae RL 12.5, EUDRAGIT\u00ae RS 100, EUDRAGIT\u00ae RS PO, EUDRAGIT\u00ae RS 30D, EUDRAGIT\u00ae RS 12.5, EUDRAGIT\u00ae NE 30D, EUDRAGIT\u00ae NE 40D.

Metadata:
- Claim Count in Document: 25.0
- Percentile: 97.0
- Lexical Diversity: 1.34483
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14779412', '14429806', '14348379', '15691539', '10569863']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7349173999459473
- 35 USC 102 Novelty (BERT): 0.563788213605295
- Combined Prediction Score: 0.7178044813118821
- Mean Citation Score: 259.428634
- Max Citation Score: 450.58203
- Similarity Product: 345.5767397979355

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test